Journal:
:international journal of hematology-oncology and stem cell research
0
roghayeh hosseinikia 1. faculty of public health, kermanshah university of medical sciences, kermanshah, iran
mohammad reza nikbakht 2. department of pharmacology, faculty of medicine, yasuj university of medical sciences , yasuj , iran
ali asghar moghadam 3. college of veterinary medicine, razi university, kermanshah, iran
ahmad tajehmiri 4. medical biology research center, kermanshah university of medical sciences , kermanshah, iran
mahboobe hosseinikia 5. faculty of public health, kermanshah university of medical sciences, kermanshah, iran
farhad oubari 6.medical biology research center, kermanshah university of medical sciences , kermanshah, iran
mesenchymal stem cells (mscs),as the major stem cells for cell therapy, have been studied from different aspects in pre-clinical and clinical settings for more than a decade. these cells modulate the immune system (humoral and cellular immune responses) in vitro by producing soluble factors (anti-inflammatory molecules) and/or making cell-cell contacts. hence they could be used in regenerative ...
